Advertisement
OM vs XTNT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OM is a Hold and XTNT is a Hold.
OM in upward trend: 10-day moving average broke above 50-day moving average on October 13, 2026
The 10-day moving average for OM crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
OM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +10.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where OM advanced for three days, in 216 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Aroon Indicator entered an Uptrend today. In 135 of 157 cases where OM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
Bearish Trend Analysis
The 10-day RSI Indicator for OM moved out of overbought territory on October 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 27 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 57 cases where OM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OM as a result. In 80 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for OM turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 34 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
OM broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.825) is normal, around the industry mean (4.142). P/E Ratio (-1.113) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.483) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. OM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
XTNT's RSI Oscillator climbs out of oversold territory
The RSI Indicator for XTNT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 26 of the 27 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for XTNT just turned positive on November 04, 2026. Looking at past instances where XTNT's MACD turned positive, the stock continued to rise in 43 of 48 cases over the following month. The odds of a continued upward trend are 90%.
Following a +7.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where XTNT advanced for three days, in 195 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
XTNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XTNT as a result. In 79 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XTNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for XTNT entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.015) is normal, around the industry mean (4.142). P/E Ratio (-3.618) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.426) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. XTNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XTNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
OM | XTNT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 23 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 96 | |
PRICE GROWTH RATING 1..100 | 60 | 79 | |
P/E GROWTH RATING 1..100 | 50 | 98 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XTNT's Valuation (23) in the Medical Specialties industry is in the same range as OM (30) in the null industry. This means that XTNT’s stock grew similarly to OM’s over the last 12 months.
XTNT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as OM (100) in the null industry. This means that XTNT’s stock grew similarly to OM’s over the last 12 months.
XTNT's SMR Rating (96) in the Medical Specialties industry is in the same range as OM (98) in the null industry. This means that XTNT’s stock grew similarly to OM’s over the last 12 months.
OM's Price Growth Rating (60) in the null industry is in the same range as XTNT (79) in the Medical Specialties industry. This means that OM’s stock grew similarly to XTNT’s over the last 12 months.
OM's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for XTNT (98) in the Medical Specialties industry. This means that OM’s stock grew somewhat faster than XTNT’s over the last 12 months.
| OM | XTNT | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 88% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 86% |
| Advances ODDS (%) | 9 days ago 85% | 8 days ago 84% |
| Declines ODDS (%) | 11 days ago 90% | 3 days ago 83% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 86% | 2 days ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OM’s FA Score shows that 1 FA rating(s) are green while XTNT’s FA Score has 1 green FA rating(s).
- OM’s FA Score: 1 green, 4 red.
- XTNT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OM’s TA Score shows that 4 TA indicator(s) are bullish while XTNT’s TA Score has 5 bullish TA indicator(s).
- OM’s TA Score: 4 bullish, 6 bearish.
- XTNT’s TA Score: 5 bullish, 3 bearish.
Price Growth
OM (@Medical/Nursing Services) experienced а -6.08% price change this week, while XTNT (@Medical/Nursing Services) price change was -6.11% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +5.70%. For the same industry, the average monthly price growth was -2.49%, and the average quarterly price growth was -1.73%.
Reported Earning Dates
OM is expected to report earnings on Feb 17, 2027.
XTNT is expected to report earnings on Nov 16, 2026.
Industries' Descriptions
@Medical/Nursing Services (+5.70% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
XTNT and
Correlation & Price change
A.I.dvisor tells us that XTNT and STRRP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and STRRP's prices will move in lockstep.
| Ticker / NAME | Correlation To XTNT | 1D Price Change % | ||
|---|---|---|---|---|
| XTNT | 100% | +1.09% | ||
| STRRP - XTNT | 31% Poorly correlated | -1.10% | ||
| CVRX - XTNT | 26% Poorly correlated | +0.70% | ||
| ACRS - XTNT | 25% Poorly correlated | +4.58% | ||
| MBOT - XTNT | 24% Poorly correlated | +5.71% | ||
| OM - XTNT | 24% Poorly correlated | -1.18% | ||
More | ||||